一个新的HLA-DQB1*03变异等位基因,HLA-DQB1*03:01:01:64,通过下一代测序确定
Diamanto Kouniaki1, Vasiliki Kitsiou1, Alexandra Tsirogianni1
1Immunology and Histocompatibility Department, Evangelismos General Hospital, Athens, Greece.
HLA
|September 23, 2024
概括
一个新的人类白细胞抗原 (HLA) -DQB1等位基因,HLA-DQB1*03:01:01:64,已被确定. 它通过单个核酸替代在内基2区别于已知的等位基因.
科学领域:
- 免疫遗传学 免疫遗传学
- 分子生物学分子生物学
- 人类白细胞抗原 (HLA) 系统
背景情况:
- 人类白细胞抗原 (HLA) 系统在免疫反应和移植中起着至关重要的作用.
- 准确的HLA等位基因鉴定对于临床应用至关重要,包括疾病关联研究和供体匹配.
研究的目的:
- 报告一个新的HLA-DQB1等位基因的发现和表征.
- 详细说明区分这种新等位基因与以前识别的特定基因变异.
主要方法:
- 使用了高分辨率的HLA类型化方法.
- 进行了序列分析以确定核酸差异.
主要成果:
- 一个新的HLA-DQB1等位基因被确定,被指定为HLA-DQB1*03:01:01:64.
- 这种新等位基因与HLA-DQB1*03:01:01:03的区别在于它在2号内的一种单核酸替代.
结论:
- 鉴定HLA-DQB1*03:01:01:64扩大了已知的HLA等位基因的多样性.
- 这一发现有助于正在进行的高分辨率HLA类型和目录的努力.
相关概念视频
Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...


